跳到正文
PR Newswire Health·· 2 小时前AI 评分8

SightMD 获评 2026 The City's Best 眼科三类奖项

SightMD Named a 2026 The City's Best Winner in Three Eye Care Categories

AI 导读

SightMD 在 2026 The City's Best 评选中同时获得 LASIK Surgery Practice、Optometrist 和 Ophthalmologist 三个眼科类别第一名。

正文 · 原文

, /PRNewswire/ -- SightMD, a leading multi-specialty eye care provider serving communities throughout New York, New Jersey, Connecticut, Pennsylvania and Massachusetts, is proud to announce that it has been named a winner in the 2026 The City's Best competition in three categories:

  • LASIK Surgery Practice
  • Optomet Practice
  • Optometrist
  • Ophthalmologist

The City's Best is a community-driven competition that invites the public to nominate and vote for their favorite Manhattan businesses and professionals across a variety of categories. The top nominees advance to the official ballot, and the organization receiving the most votes is named the first-place winner in its category.

SightMD's recognition across three eye care categories reflects the confidence patients and community members place in its doctors, clinical teams and staff. It also highlights the organization's ongoing commitment to delivering comprehensive, high-quality eye care using advanced technology and a patient-first approach.

"We are incredibly honored to receive this recognition in three important areas of eye care," said Jonathan Ellant, MD, SightMD surgeon. "These awards reflect the dedication of our doctors, clinical teams and staff, who work every day to provide an exceptional experience and the highest level of care for our patients. We are especially grateful to everyone who voted and continues to place their trust in SightMD."

From routine eye examinations and the management of complex eye conditions to advanced cataract surgery and vision correction procedures such as LASIK, SightMD offers patients access to a broad range of services within one trusted network.

SightMD thanks its patients, employees and surrounding communities for helping make this achievement possible. The organization remains committed to expanding access to exceptional eye care and helping patients enjoy clearer vision at every stage of life.

For more information or to schedule an appointment, please visit www.SightMD.com or call 1-855-295-4144.

SightMD is actively seeking ophthalmology professionals who are interested in joining its outstanding team. If you are an ophthalmology practice owner interested in merging or selling your practice, please contact the Chief Medical Officer, Brad Kligman, at [email protected]

About The City's Best

The City's Best is an annual competition recognizing outstanding businesses and professionals throughout Manhattan. Members of the public nominate their favorite local organizations in categories spanning health and wellness, food and dining, education, professional services, shopping, entertainment and more. The leading nominees advance to a public voting round, with one first-place winner selected in each category based on the highest number of votes. The program is promoted by Schneps Media across its network of local print and digital publications. Additional information is available through The City's Best.

About SightMD

SightMD is a rapidly-growing integrated ophthalmic group, offering patients access to over 100 doctors through the convenience of 38 locations across New York. SightMD's track record of providing clinically-excellent care spans over 50 years, and its services include LASIK laser vision correction, laser cataract surgery and lens implantation, oculoplastic surgery, general eye exams, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. For more information about SightMD, please visit sightmd.com

SOURCE SightMD

来源:PR Newswire Health · prnewswire.com

AI 摘要声明:站内标题、摘要与推荐理由由模型基于公开来源生成,属机器生成内容,非原文;本页内容仅供医药行业信息参考,不构成医疗建议、诊断或用药依据。